Prometheus Biosciences, Inc. SEC Filings

Filed On	Filing
27 Jun 2023	FORM 15-12G
16 Jun 2023	Form 4: Hendrix Martin, Director Returned 2,071 shares to the issuer · Disposed of 60,500 Stock Option (right to buy) (Disposition to Issuer)
16 Jun 2023	Form 4: Laur James, Director Returned 2,071 shares to the issuer · Disposed of 60,500 Stock Option (right to buy) (Disposition to Issuer)
16 Jun 2023	Form 4: Stenhouse Mark, Chief Operating Officer Returned 26,754 shares to the issuer · Disposed of 471,038 Stock Option (right to buy) (Disposition to Issuer)
16 Jun 2023	Form 4: Szela Mary T, Director Returned 2,071 shares to the issuer · Disposed of 60,500 Stock Option (right to buy) (Disposition to Issuer)
16 Jun 2023	Form 4: McKenna Mark C., Director Returned 178,098 shares to the issuer · Disposed of 2,027,447 Stock Option (right to buy) (Disposition to Issuer)
16 Jun 2023	Form 4: Swain Judith L, Director Returned 2,071 shares to the issuer · Disposed of 50,500 Stock Option (right to buy) (Disposition to Issuer)
16 Jun 2023	Form 4: Papa Joseph C, Director Returned 17,278 shares to the issuer · Disposed of 89,708 Stock Option (right to buy) (Disposition to Issuer)
16 Jun 2023	Form 4: Hassan Fred, Director Returned 2,123 shares to the issuer · Disposed of 61,554 Stock Option (right to buy) (Disposition to Issuer)
16 Jun 2023	Form 4: Marshall Keith W, Chief Financial Officer Returned 87,973 shares to the issuer · Disposed of 517,533 Stock Option (right to buy) (Disposition to Issuer)
16 Jun 2023	Form 4: Adams Helen C., Director Returned 2,674 shares to the issuer · Disposed of 52,609 Stock Option (right to buy) (Disposition to Issuer)
16 Jun 2023	25-NSE
16 Jun 2023	S-8 POS
16 Jun 2023	S-8 POS
16 Jun 2023	POSASR
16 Jun 2023	8-K: Completion of Acquisition or Disposition of Assets; Notice of Delisting or Failure to Satisfy a Listing Rule +4 more
15 Jun 2023	8-K: Submission of Matters to a Vote of Security Holders
06 Jun 2023	DEFA14A
02 Jun 2023	Form 4: McKenna Mark C., Director Received 122,531 shares by exercise or conversion ($355K)
02 Jun 2023	Form 4: Marshall Keith W, Chief Financial Officer Received 78,162 shares by exercise or conversion ($242K)

Comments